Electrophoresis & Blotting
Imaging Systems & Software
Liquid Handling & Pipetting
Nucleic Acid Extraction & Purification
Protein Sample Preparation
Protein Interaction Analysis
General Laboratory Equipment
GE Healthcare Life Sciences
IN Cell Analyzer
Life Technologies - Invitrogen
Biochemical Assay Kits
cDNA Synthesis, Library, & Cloning Kits
Cell Analysis Kits
Cell Based Assay Kits
Enzyme Detection & Activity Assays
Forensic Testing Kits
Impurity & Contamination Detection Kits
Luminex® Protein Assays
Mass Spectrometry Kits
Microbial Detection & Identification Kits
Microbial Isolation & Concentration Kits
Nucleic Acid Detection & Analysis Kits
Nucleic Acid Labeling Kits
Nucleic Acid Purification Kits & Reagents
Nucleic Acid Quantitation Assay Kits
Protein Analysis Kits
Protein Expression Kits
Protein Purification Kits
Real-Time PCR & Endpoint RT-PCR Kits
RNA Amplification Kits
Sequencing Kits & Reagents
Western Blotting Kits
Life Technologies traces its roots back to 1962 with the creation of Grand Island Biological Company (GIBCO) in Grand Island, New York, making serum harvested from horses raised on their land.
The original Life Technologies, Inc. (LTI), a subsidiary of Dexter Corp., was founded in 1983 by the merger of Bethesda Research Laboratories, Inc. (BRL) and GIBCO Corporation. Life Technologies was bought out by the smaller, cash-rich Invitrogen in 2000, who gradually discontinued the use of the name Life Technologies.
The new Life Technologies Corp. (NASDAQ: LIFE) was formed November 21, 2008 with the completion of the merger of Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:AB) Applied Biosystems. The company elected to resurrect the Life Technologies name for which it still held the trademark.
Applied Biosystems (formerly GeneCo) was founded in 1981 by Sam Eletr and Andre Marion as a biochemical and manufactured diagnostic research instrument manufacturer. Perkin Elmer acquired Applied Biosystems in 1983 and held it until 2000 when it was released as a publicly traded company. The former parent Perkin Elmer then became Applera. By 2002, Applied Biosystems reached revenues of $1.6 billion and maintained a variety of products including the SOLiD System - a next-gen DNA sequencing platform.
Lyle Turner, Joe Fernandez and William MacConnell (who was later bought out) founded Invitrogen in September 1987. They focused on developing products for the niche within the molecular biology research market for kits, reagents and services. They advertised in scientific journals, catalogs and everywhere they thought scientists would scan. Within three months, they sold their first kit, The Librarian, for $3,200. In 1998, Invitrogen offered more than 2,000 products. Invitrogen’s initial public offering (IPO) was made in February 1999 and raised $48.1M.
New England Biolabs (NEB)
PCR, Polymerases & Amplification Technologies
DNA Modifying Enzymes & Cloning Technologies
Library Preparation for Next Generation Sequencing
Markers & Ladders
Protein Expression & Purification Technologies
Biochemicals & Labware
Cell Health & Metabolism
Cloning & DNA Markers
DNA & RNA Purification
Imaging & Immunological Detection
Industrial & Environmental Monitoring
Protein Purification & Interactions
Reporter Assays & Transfection
Stem Cell Research
DNA Isolation Kits
RNA Isolation Kits
Life Science Research
Human ID & Forensics
Animal Pathogen ID
Genes & Pathways
Roche Life Science
Life Technologies - Thermo Scientific
Phusion™ DNA Polymerases
GeneRuler™ DNA Ladders
SuperSignal™ Chemiluminescent Substrates
Slide-A-Lyzer™ Dialysis Cassettes
Pierce™ Primary Antibodies
High-Content Screening Instruments
Buffers & Solutions
Columns & Plastics
Since its inception in 1994, Zymo Research has been proudly serving the scientific community by providing innovative, high quality research tools at affordable prices. Our vision… “The Beauty of Science is to Make Things Simple” is now truer than ever. Whether it's Epigenetics, DNA, RNA, E. coli, or Yeast based research, our philosophy remains the same: to provide the highest quality products in the industry while ensuring they are both simple to use and reliable in their performance.
Although historically recognized for its innovative DNA and RNA purification technologies, Zymo Research has recently received much attention for its rapidly expanding epigenetics portfolio of products. Branding ourselves “The Epigenetics Company” it is our objective to develop and provide the most comprehensive set of research tools for DNA methylation analysis and epigenetics research available today.
Thousands of peer-reviewed scientific publications from researchers around the world feature our epigenetic technologies in addition to our other products. To date, our EZ DNA Methylation™ family of products remain the most popular and cited technologies available for bisulfite treatment of DNA for methylation-specific analysis. However, we have many new technologies also developed for histone, chromatin, and small RNA analysis and for the next era of DNA methylation detection and analysis.
FOR OTHER PRODUCTS AND BRANDS THAT YOU COULD NOT FIND ON THIS WEB SITE
OR OUR PRODUCT CATALOGUE, PLEASE SEND AN E-MAIL TO firstname.lastname@example.org.